Omnipod 5 DEXG7G6 intro(GEN 5)s
Ended Awarded
- Contract number
- SPE2DB25FFCQ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,956
Award facts
- Contract value 100% obligated
- $25,955.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,955.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for OmniPod 5 with Dexcom G7 integration (Generation 5) diabetes management supplies. This non-competitive delivery order, issued on August 11, 2025, represents performance through August 12, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) relationship with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as the primary pharmaceutical and medical supply vehicle for supporting military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has established itself as a critical federal medical procurement vendor through its extensive portfolio of competitive awards with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for diabetes management technology reflects the contractor's capabilities in providing specialized medical supplies and aligns with the DLA's broader strategy to maintain robust pharmaceutical supply chains supporting military personnel and veteran healthcare worldwide.
Quick answers
Who was awarded contract SPE2DB25FFCQ3?
SPE2DB25FFCQ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FFCQ3 worth?
The government has obligated $25,956 on SPE2DB25FFCQ3.
Is contract SPE2DB25FFCQ3 an order under another contract?
Yes. SPE2DB25FFCQ3 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFCQ3 competed?
The extent of competition for SPE2DB25FFCQ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award